SCHEMBL6995169

SCHEMBL6995169

Cc1nc(Nc2c(Cl)cc(Cl)cc2Cl)n2ncc(CCCCC3CC3)c2n1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 17/20 0.38
MEN1 O00255 1/20 0.37
NR1I2 O75469 1/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
NMT1 P30419 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7003907 0.97 CRHR1 (0.39) CRHR1MEN1NR1I2GMNNLMNA
SCHEMBL6996246 0.95 CRHR1 (0.35) CRHR1MEN1NR1I2GMNNLMNA
SCHEMBL6996135 0.92 CRHR1 (0.35) CRHR1MEN1NR1I2GMNNLMNA
SCHEMBL6997366 0.89 CRHR1 (0.35) CRHR1NMT1
SCHEMBL6999813 0.88 CRHR1 (0.30) CRHR1
SCHEMBL7000023 0.87 CRHR1 (0.38) CRHR1
SCHEMBL7002229 0.86 CRHR1 (0.35) CRHR1NMT1
SCHEMBL6997210 0.86 CRHR1 (0.36) CRHR1
SCHEMBL7001309 0.85 CRHR1 (0.31) CRHR1
SCHEMBL7000593 0.84 CRHR1 (0.38) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1090005-B1 PYRAZOLO 1,5-a]TRIAZINE CORTICOTROPIN RELEASING FACTOR ANTAGONISTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2003-08-20 EP claimed
US-6509338-B1 Psychiatric disorders and neurological diseases including affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease, BRISTOL-MYERS SQUIBB COMPANY 2003-01-21 US claimed
EP-1090005-B1 PYRAZOLO 1,5-a]TRIAZINE CORTICOTROPIN RELEASING FACTOR ANTAGONISTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2003-08-20 EP disclosed
US-6509338-B1 Psychiatric disorders and neurological diseases including affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease, BRISTOL-MYERS SQUIBB COMPANY 2003-01-21 US disclosed